AG
IMMU

Advisor Group’s Immunomedics Inc IMMU Stock Holding History

Advisor Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$244K Sell
11,534
-903
-7% -$15.9K ﹤0.01% 2232
2019
Q3 		$164K Buy
12,437
+249
+2% +$3.66K ﹤0.01% 2476
2019
Q2 		$168K Sell
12,188
-40
-0.3% -$602 ﹤0.01% 2461
2019
Q1 		$235K Buy
12,228
+1,569
+15% +$25.3K ﹤0.01% 2149
2018
Q4 		$152K Buy
10,659
+304
+3% +$6.04K ﹤0.01% 2300
2018
Q3 		$216K Buy
10,355
+1,505
+17% +$35.6K ﹤0.01% 2103
2018
Q2 		$210K Buy
8,850
+3,560
+67% +$71.5K ﹤0.01% 1940
2018
Q1 		$78K Buy
5,290
+90
+2% +$1.47K ﹤0.01% 2756
2017
Q4 		$84K Buy
5,200
+1,765
+51% +$20.8K ﹤0.01% 2709
2017
Q3 		$48K Buy
3,435
+2,235
+186% +$22.3K ﹤0.01% 2979
2017
Q2 		$11K Hold
1,200
– – ﹤0.01% 3890
2017
Q1 		$7K Hold
1,200
– – ﹤0.01% 3996
2016
Q4 		$5K Buy
+1,200
New +$3.55K ﹤0.01% 3965

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Advisor Group's IMMU Position: Q4 2019 in Review

Advisor Group reduced its Immunomedics Inc (IMMU) stake by 7.3% in Q4 2019, selling an estimated $15.9K and leaving 11,534 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Advisor Group first reported a position in IMMU in Q4 2016 and has held it in 13 quarters since. 245 funds tracked by Wall St. Rank hold IMMU as of Q4 2019.

  • Advisor Group held 11,534 shares of Immunomedics Inc worth $244K as of Q4 2019.
  • Advisor Group sold 903 Immunomedics Inc shares in Q4 2019, an estimated $15.9K.
  • Immunomedics Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2232 holding.
  • Advisor Group first reported a position in Immunomedics Inc in Q4 2016 and has held it in 13 quarters since.
  • 245 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.